Cybin Completes Dosing in Phase 2 Study of CYB003 for the ... - Business Wire

Submitted by Anonymous (not verified) on Tue, 10/03/2023 - 11:30

Cybin Completes Dosing in Phase 2 Study of CYB003 for the ...  Business Wire